Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand.
about
Endocannabinoid signaling in female reproductionThe serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptorsReduced expression of glutamate receptors and phosphorylation of CREB are responsible for in vivo Delta9-THC exposure-impaired hippocampal synaptic plasticityControl of synaptic function by endocannabinoid-mediated retrograde signalingFatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55The role of sex steroid hormones, cytokines and the endocannabinoid system in female fertilityEnzymatic pathways that regulate endocannabinoid signaling in the nervous systemMonoacylglycerols activate TRPV1--a link between phospholipase C and TRPV1Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.Distinct functional and anatomical architecture of the endocannabinoid system in the auditory brainstem.Cannabinoid receptor 2 mediates the retention of immature B cells in bone marrow sinusoidsFull mass spectrometric characterization of human monoacylglycerol lipase generated by large-scale expression and single-step purification.Anandamide potentiation of miniature spontaneous excitatory synaptic transmission is mediated via IP3 pathway.Assessment of a spectrophotometric assay for monoacylglycerol lipase activity.Monoglyceride lipase deficiency affects hepatic cholesterol metabolism and lipid-dependent gut transit in ApoE-/- mice.Localization of the cannabinoid CB1 receptor and the 2-AG synthesizing (DAGLα) and degrading (MAGL, FAAH) enzymes in cells expressing the Ca(2+)-binding proteins calbindin, calretinin, and parvalbumin in the adult rat hippocampus.A putative 'pre-nervous' endocannabinoid system in early echinoderm development.Distribution of lipids in human brain.Pharmacology of signaling induced by dopamine D(1)-like receptor activationPeroxisomal and microsomal lipid pathways associated with resistance to hepatic steatosis and reduced pro-inflammatory state.Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol.Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerolMetabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways.The role of cannabinoids in regulation of nausea and vomiting, and visceral pain.Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.Cannabidiol as potential anticancer drug.Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults.The preparation of 2-O-[1'-C]arachidonoyl-1-O-stearoyl-sn-glycerol.JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy.A methodology for radiolabeling of the endocannabinoid 2-arachidonoylglycerol (2-AG).Monoglyceride lipase deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance.Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain.Identification of small molecules that selectively inhibit diacylglycerol lipase-α activity.The endogenous cannabinoid 2-arachidonoylglycerol is intravenously self-administered by squirrel monkeysInhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ.Endocannabinoid system in cardiovascular disorders - new pharmacotherapeutic opportunities.Cannabinoid receptor 2 positions and retains marginal zone B cells within the splenic marginal zoneNuclear diacylglycerol lipase-α in rat brain cortical neurons: evidence of 2-arachidonoylglycerol production in concert with phospholipase C-β activity.Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation.
P2860
Q24599033-4974D2A2-A0FB-4F2C-8E32-5FF401133A97Q24602845-4D0F9111-A109-455E-9931-E745371764CBQ24642505-EDD1B761-1393-48E9-A764-1B4C720D1A39Q26824698-C88CD770-7DFA-436D-9587-FB1BFF7D55A0Q28285103-27D6542F-3B6C-403F-B1AD-3524E3854B9CQ28296479-23528BFF-0D62-4DC9-90A5-DD7A2744CCB0Q28303095-56DA09BE-1BE7-4C9F-8288-F1A10C51E811Q28390932-224FF51E-2129-4B08-9100-973E9E06AEE0Q28535638-E79119A4-6AE0-4693-A919-B788820F6149Q30366778-2AB7A2D0-38BC-4D41-BAF8-B5D0D708C3A2Q30481732-1A656D17-36C3-4331-B738-B78AB013CE4AQ30491268-4328E312-B0EA-414D-9E09-03FCFAA11F71Q33331431-3104291F-7BDC-4857-8DD6-93AFE820F3ECQ33699215-DB69978F-53DA-4971-B336-190E6E9851D1Q33749499-D9513928-9DCE-4065-A5BB-E028CB213473Q33779386-1CCA0168-4975-4715-B114-7B31FF0B7EC7Q33814030-ECE5D40B-78AE-4B61-BB1B-2EAE4BA94596Q33837421-900A1B4C-9D4D-4CEB-999E-93F59F9EC85EQ33856003-B1AFAB1B-FEEA-4B5C-B606-0C13E8AC5D1CQ34126949-F1266395-ADC2-4BAF-A6C6-B2FF2FC42D78Q34155467-7BDDB60C-0B46-4F79-948F-47EBBD8CEC20Q34165188-184D10C0-14B7-471F-A62A-8FB64585FCF6Q34254854-FC1E9D74-717C-401D-8359-01096DE594F0Q34328745-6B62DD27-D20A-471A-A2A6-58FC0A59003BQ34464535-57690FB8-E61A-49FC-BFF0-08657C88533DQ34547759-071B5A4E-E9E1-4ABE-B38A-9E7284375D16Q34637516-7864752D-2ACD-431B-9DC1-7992F83A19FDQ34642593-73B2A81C-1712-4493-A1ED-FD77EC9A333AQ34680798-2437ECA9-5981-4874-8DB5-E296A6DB592DQ34715335-F704D8B9-4A59-4510-9FBC-37C330EF099DQ34722934-8D8226D7-4D0D-4559-907D-B71DF1D3277FQ34978868-1D988AC2-A3DE-41A5-8C95-F09352BA75D3Q35013497-DFECD75E-A67E-4774-8AFA-2E656FE5A57DQ35045024-560C52FD-7611-4734-96FF-43B2BD5A51AEQ35070299-A9E56982-F2CF-4A5C-8B8B-990270A47531Q35193317-49837652-8FF6-4676-AADA-26D12B628C41Q35228889-5AED43C8-AE30-45A9-B556-34D555D447D9Q35237510-53C00F12-4DF7-49C5-A028-0813DC585D66Q35325228-DDB0F6B4-838A-412D-B1EB-3F9E0438038FQ35651950-C210BC01-0768-4D30-BBE1-38D22F6344E4
P2860
Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Biochemistry, pharmacology and ...... s cannabinoid receptor ligand.
@ast
Biochemistry, pharmacology and ...... s cannabinoid receptor ligand.
@en
Biochemistry, pharmacology and ...... s cannabinoid receptor ligand.
@nl
type
label
Biochemistry, pharmacology and ...... s cannabinoid receptor ligand.
@ast
Biochemistry, pharmacology and ...... s cannabinoid receptor ligand.
@en
Biochemistry, pharmacology and ...... s cannabinoid receptor ligand.
@nl
prefLabel
Biochemistry, pharmacology and ...... s cannabinoid receptor ligand.
@ast
Biochemistry, pharmacology and ...... s cannabinoid receptor ligand.
@en
Biochemistry, pharmacology and ...... s cannabinoid receptor ligand.
@nl
P2093
P921
P1476
Biochemistry, pharmacology and ...... s cannabinoid receptor ligand.
@en
P2093
Maiko Gokoh
Seishi Kishimoto
Takayuki Sugiura
P304
P356
10.1016/J.PLIPRES.2006.03.003
P577
2006-04-19T00:00:00Z